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To date it has been generally assumed for early stage disease that although for some 5-10 years after treatment the survival experience of this patient subgroup might be no different from that expected in the matched group, thereafter the death rate of this subgroup becomes lower than that of the matched group. This implies that surviving cancer patients cured of their disease tend to die of other conditions at a higher than normal rate as they become older, and therefore cancer is never totally cured. Our conclusion is that at least for cancer of the glottic larynx, the answer to the question "Can cancer totally be cured?" is "Yes to at least 15-years posttreatment and also probably to 25 years".
Table 12
Complete life analysis to 15-years post-treatment for 294 stage T1N0 and 145 stage T2N0 cases where all patients are excluded who have died with cancer of the larynx present or with cancer of the lung present. For stage T1N0 and T2N0 and survival time T=10-20 years agreement, is less than or equal to 1 standard error of the observed T-year survival fraction calculated using the Kaplan-Meier method [5] . These results show that the Haybittle [7] definition of cancer cure as understood by the man-in-the-street has been achieved: "The complete elimination of disease, so that a patient cured of cancer would be one whose subsequent medical history and length of life was completely unaffected by their having had cancer". In each, the frequency distribution of survival times of defined groups of cancer deaths is lognormally distributed: larynx only (SLN), larynx and lung (TCR) and all cancers (ACC). All models each have three unknown parameters but it was possible to assume a value for the lognormal parameter S a priori. By reduction to two unknown parameters the model stability has been improved.
The material used to validate the methodology consisted of case histories of 965 patients, all treated during the period 1944-1968 by Dr Manuel Lederman of the Royal Marsden Hospital, London, with follow-up to 1988. This provided a follow-up range of 20-44 years and enabled predicted long-term survival fractions to be compared with the actual survival fractions, calculated by the Kaplan and Meier method [5] .
The TCR and ACC models are better than the SLN model and for a maximum short-term follow-up of 6 years, the 20 and 25 year survival fractions could be predicted. Therefore the number of follow-up years saved are respectively 14 years and 19 years. Clinical trial results using the TCR and ACC models can thus be analysed much earlier than currently possible.
Absolute cure from cancer was also studied, using not only the prediction models which incorporate a parameter for a statistically cured fraction of patients C SLN , C TCR and C ACC , but because of the long follow-up range of 20-44 years, also by Complete Life Analysis. The survival experience of those who did not die of their original cancer of the larynx was compared to the expected survival experience of a population with the same age, birth cohort and sex structure. [6] in 1968. This was described in the following terms "If a group of patients subsequently show an annual death rate from all causes which is similar to that of the normal population of the same age and sex structure, then this group can be said to be cured".
